EA201490233A8 - Стабильные лекарственные формы артеролана и пиперахина - Google Patents

Стабильные лекарственные формы артеролана и пиперахина

Info

Publication number
EA201490233A8
EA201490233A8 EA201490233A EA201490233A EA201490233A8 EA 201490233 A8 EA201490233 A8 EA 201490233A8 EA 201490233 A EA201490233 A EA 201490233A EA 201490233 A EA201490233 A EA 201490233A EA 201490233 A8 EA201490233 A8 EA 201490233A8
Authority
EA
Eurasian Patent Office
Prior art keywords
piperahin
arterolana
medical forms
stable medical
stable
Prior art date
Application number
EA201490233A
Other languages
English (en)
Russian (ru)
Other versions
EA201490233A1 (ru
Inventor
Арно Аппавоо Эноуз
Хариш Кумар Мадан
Сумит Мадан
Анупам Трехан
Пунеет Тьяги
Винод Кумар Арора
Саньюкта Бхаттачария
Арьюн Рой
Аннамдевара Балайи
Original Assignee
Ранбакси Лабораториз Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/183,119 external-priority patent/US8664265B2/en
Application filed by Ранбакси Лабораториз Лимитед filed Critical Ранбакси Лабораториз Лимитед
Publication of EA201490233A1 publication Critical patent/EA201490233A1/ru
Publication of EA201490233A8 publication Critical patent/EA201490233A8/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EA201490233A 2011-07-14 2012-07-13 Стабильные лекарственные формы артеролана и пиперахина EA201490233A8 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13/183,119 US8664265B2 (en) 2005-05-18 2011-07-14 Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
IN2703DE2011 2011-09-19
IN2156DE2012 2012-07-12
PCT/IB2012/053614 WO2013008218A1 (en) 2011-07-14 2012-07-13 Stable dosage forms of arterolane and piperaquine

Publications (2)

Publication Number Publication Date
EA201490233A1 EA201490233A1 (ru) 2014-07-30
EA201490233A8 true EA201490233A8 (ru) 2015-01-30

Family

ID=47505579

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201490233A EA201490233A8 (ru) 2011-07-14 2012-07-13 Стабильные лекарственные формы артеролана и пиперахина

Country Status (10)

Country Link
EP (1) EP2731603A1 (zh)
JP (1) JP2014522856A (zh)
KR (1) KR20140053169A (zh)
CN (1) CN103930107A (zh)
AP (1) AP2014007413A0 (zh)
AU (1) AU2012282077A1 (zh)
CA (1) CA2850089A1 (zh)
EA (1) EA201490233A8 (zh)
MX (1) MX2014000463A (zh)
WO (1) WO2013008218A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2015008748A0 (en) 2013-02-28 2015-09-30 Sun Pharmaceutical Ind Ltd Stable dispersible formulation of arterolane maleate and piperaquine and process of preparation thereof
KR101698003B1 (ko) * 2016-06-20 2017-01-19 여오영 퀴닌 염 현탁액을 포함하는 항암 치료를 위한 국소 투여용 주사제 조성물
BR112020011506A2 (pt) * 2017-12-12 2020-11-17 Intervet International B.V. composições farmacêuticas de isoxazolina implantáveis e usos das mesmas
TW202220645A (zh) * 2020-08-14 2022-06-01 印度商太陽製藥工業有限公司 用於治療瘧疾的固定劑量組合藥物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486199B1 (en) 2001-06-21 2002-11-26 Medicines For Malaria Venture Mmv International Centre Cointrin Spiro and dispiro 1,2,4-trioxolane antimalarials
US6906205B2 (en) 2002-06-21 2005-06-14 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US6825230B2 (en) 2002-06-21 2004-11-30 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trixolane antimalarials
CN101272777B (zh) * 2005-05-18 2013-01-30 兰贝克赛实验室有限公司 螺和二螺1,2,4-三氧戊环抗疟药的稳定剂型
AP2525A (en) * 2006-05-17 2012-12-05 Ranbaxy Lab Ltd Antimarial therapy using a combination of synthetic artemisinin derivative and bisquinoline derivative

Also Published As

Publication number Publication date
EP2731603A1 (en) 2014-05-21
JP2014522856A (ja) 2014-09-08
CA2850089A1 (en) 2013-01-17
AP2014007413A0 (en) 2014-02-28
KR20140053169A (ko) 2014-05-07
CN103930107A (zh) 2014-07-16
WO2013008218A1 (en) 2013-01-17
EA201490233A1 (ru) 2014-07-30
MX2014000463A (es) 2014-07-09
AU2012282077A1 (en) 2014-01-30
AP3777A (zh) 2016-08-31

Similar Documents

Publication Publication Date Title
CY1122853T1 (el) Σταθερα σκευασματα λινακλοτιδης
CY1121150T1 (el) Νευροδραστικα 19-αλκοξυ-17-υποκατεστημενα στεροειδη, χρησιμα σε μεθοδους θεραπειας
EA201891103A1 (ru) Композиции для лечения спинальной мышечной атрофии
EA202090486A3 (ru) Соединения для лечения спинальной мышечной атрофии
CY1118379T1 (el) Αναστολεις ιου ηπατιτιδας c
EA201300989A1 (ru) Водная фармацевтическая композиция тапентадола для перорального введения
EA201390766A1 (ru) БЕНЗОКСАЗЕПИНЫ КАК ИНГИБИТОРЫ PI3K/mTOR И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ И ПОЛУЧЕНИЯ
EA202190619A1 (ru) Противовирусные соединения
EA201591166A1 (ru) Ингибиторы аутотаксина
EA201391087A1 (ru) Оральные лекарственные формы препарата тазоцитиниба с модифицированным высвобождением
UA109010C2 (en) MORPHOLINOPYRIMIDINES AND THEIR APPLICATIONS IN THERAPY
EA201491672A1 (ru) Гетероциклильные соединения как ингибиторы mek
EA201391029A1 (ru) Производные оксазина и их применение при лечении неврологических нарушений
EA201590371A1 (ru) 1,4-дизамещенные аналоги пиридазина и способы лечения связанных с дефицитом smn состояний
EA201500298A1 (ru) Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы
EA201591195A1 (ru) Новые хинолоновые производные
EA201070597A1 (ru) Антибактериальные аналоги аминогликозида
EA201490471A1 (ru) Пиридазиноновые соединения и их применение в качестве ингибиторов daao
EA201600337A1 (ru) 2,6-замещенные пуриновые производные и их применение в лечении пролиферативных заболеваний
EA201691216A1 (ru) Композиции линаклотида с замедленным высвобождением
EA201301019A1 (ru) Бензодиоксановые ингибиторы продуцирования лейкотриена
EA201270741A1 (ru) Пероральные композиции и липофильные соли метилналтрексона
EA201370166A1 (ru) Содержащие диарилацетиленгидразид ингибиторы тирозинкиназы
EA201490037A1 (ru) Антагонисты trpv4
EA201400976A1 (ru) Бензодиоксаны в комбинации с другими активными средствами для ингибирования продуцирования лейкотриена